1-5 of 5
Vincent H. J. van der Velden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial

Clinical Trials & Observations
Anita W. Rijneveld, Bronno van der Holt, Okke de Weerdt, Bart J. Biemond, Arjen A. van de Loosdrecht, Lotte E. van der Wagen, Mar Bellido, Michel van Gelder, Walter J. F. M. van der Velden, Dominik Selleslag, Daniëlle van Lammeren-Venema, Constantijn J. M. Halkes, Rob Fijnheer, Violaine Havelange, Geerte L. van Sluis, Marie-Cecile Legdeur, Dries Deeren, Alain Gadisseur, Harm A. M. Sinnige, Dimitri A. Breems, Aurélie Jaspers, Ollivier Legrand, Wim E. Terpstra, Rinske S. Boersma, Dominiek Mazure, Agnes Triffet, Lidwine W. Tick, Karolien Beel, Johan A. Maertens, H. Berna Beverloo, Marleen Bakkus, Christa H. E. Homburg, Valerie de Haas, Vincent H. J. van der Velden, Jan J. Cornelissen, the Dutch-Belgian HOVON Cooperative group
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1115–1125.
https://doi.org/10.1182/bloodadvances.2021005624
Published: 2022
Includes: Supplemental data
Journal Articles

Expert-independent classification of mature B-cell neoplasms using standardized flow cytometry: a multicentric study

Sebastian Böttcher, Robby Engelmann, Georgiana Grigore, Paula Fernandez, Joana Caetano, Juan Flores-Montero, Vincent H. J. van der Velden, Michaela Novakova, Jan Philippé, Matthias Ritgen, Leire Burgos, Quentin Lecrevisse, Sandra Lange, Tomas Kalina, Javier Verde Velasco, Rafael Fluxa Rodriguez, Jacques J. M. van Dongen, Carlos E. Pedreira, Alberto Orfao,
Journal: Blood Advances
Blood Adv (2022) 6 (3): 976–992.
https://doi.org/10.1182/bloodadvances.2021005725
Published: 2022
Includes: Supplemental data
Journal Articles

PML-controlled responses in severe congenital neutropenia with ELANE -misfolding mutations

Clinical Trials & Observations
Patricia A. Olofsen, Dennis A. Bosch, Onno Roovers, Paulina M. H. van Strien, Hans W. J. de Looper, Remco M. Hoogenboezem, Sander Barnhoorn, Pier G. Mastroberardino, Mehrnaz Ghazvini, Vincent H. J. van der Velden, Eric M. J. Bindels, Emma M. de Pater, Ivo P. Touw
Journal: Blood Advances
Blood Adv (2021) 5 (3): 775–786.
https://doi.org/10.1182/bloodadvances.2020003214
Published: 2021
Includes: Supplemental data
Journal Articles

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

Peter Bader, Emilia Salzmann-Manrique, Adriana Balduzzi, Jean-Hugues Dalle, Ann E. Woolfrey, Merav Bar, Michael R. Verneris, Michael J. Borowitz, Nirali N. Shah, Nathan Gossai, Peter J. Shaw, Allen R. Chen, Kirk R. Schultz, Hermann Kreyenberg, Lucia Di Maio, Gianni Cazzaniga, Cornelia Eckert, Vincent H. J. van der Velden, Rosemary Sutton, Arjan Lankester, Christina Peters, Thomas E. Klingebiel, Andre M. Willasch, Stephan A. Grupp, Michael A. Pulsipher
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3393–3405.
https://doi.org/10.1182/bloodadvances.2019000449
Published: 2019
Includes: Supplemental data
Journal Articles

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study

Clinical Trials & Observations
Marius Flasinski, Kira Scheibke, Martin Zimmermann, Ursula Creutzig, Katarina Reinhardt, Femke Verwer, Valerie de Haas, Vincent H. J. van der Velden, Christine von Neuhoff, C. Michel Zwaan, Dirk Reinhardt, Jan-Henning Klusmann
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1532–1540.
https://doi.org/10.1182/bloodadvances.2018018945
Published: 2018
Includes: Supplemental data